Ildong Pharmaceutical Posts 9.2 Billion Won Operating Profit in Q1, Up 120% Year-on-Year
Ildong Pharmaceutical announced on May 13 that its consolidated operating profit for the first quarter of this year was 9.2 billion won, marking a 120% increase compared to the same period last year.
Sales reached 142 billion won, up 4.4% year-on-year, and net profit for the period surged by 1,376% to 7.4 billion won.
Hot Picks Today
Even with High Oil Price Relief Payment, Additional 300,000 Won Per Person to Be Provided... Applications Open from the 18th in This Region
- "Invested 95% in Hynix and Reached 10 Billion Won"... Japanese Investor's Proof Post Goes Viral
- Parents Sue After Losing Son Who Followed ChatGPT Advice to "Take the Medication"
- "You Don't Need to Go to the Gym": The Best Exercises for Lowering Hypertension
- "That Thing Wakes Up Every Night" ... Suspicious Object Covers Rural Village
A representative from Ildong Pharmaceutical explained, "Our main business sectors—including prescription drugs, over-the-counter medicines, and healthcare—showed balanced growth." The representative added, "Operating profit also increased, driven by improvements in the cost-to-sales ratio resulting from cost innovation."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
